Authors: Brockunier, LL Parmee, ER Ok, HO Candelore, MR Cascieri, MA Colwell, LF Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Tota, L Wyvratt, MJ Fisher, MH Weber, AE

Citation: Ll. Brockunier et al., Human beta 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides, BIOORG MED, 10(18), 2000, pp. 2111-2114

Authors: Ok, HO Reigle, LB Candelore, MR Cascieri, MA Colwell, LF Deng, L Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Strader, CD Tota, L Wang, P Wyvratt, MJ Fisher, MH Weber, AE

Citation: Ho. Ok et al., Substituted oxazole benzenesulfonamides as potent human beta(3) adrenergicreceptor agonists, BIOORG MED, 10(14), 2000, pp. 1531-1534

Authors: Forrest, MJ Hom, G Bach, T Candelore, MR Cascieri, MA Strader, C Tota, L Fisher, MH Szumiloski, J Ok, HO Weber, AE Wyvratt, M Vicario, P Marko, O Deng, LP Cioffe, C Hegarty-Friscino, B MacIntyre, E

Citation: Mj. Forrest et al., L-750355, a human beta 3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey, EUR J PHARM, 407(1-2), 2000, pp. 175-181

Authors: Parmee, ER Naylor, EM Perkins, L Colandrea, VJ Ok, HO Candelore, MR Cascieri, MA Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Miller, RR Stearns, RA Strader, CD Tota, L Wyvratt, MJ Fisher, MH Weber, AE

Citation: Er. Parmee et al., Human beta(3) adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides, BIOORG MED, 9(5), 1999, pp. 749-754